Feasibility of BabyGentleStick- Adult Pilot Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02947646 |
|
Recruitment Status :
Completed
First Posted : October 28, 2016
Last Update Posted : January 24, 2018
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Lack of Adverse Events Reduced Pain Response | Device: BabyGentleStick™ ON Device: BabyGentleStick™ OFF | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 20 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Device Feasibility |
| Study Start Date : | November 2016 |
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | December 2016 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: BabyGentleStick™ ON
Experimental intervention to be compared to the Active Comparator.
|
Device: BabyGentleStick™ ON |
|
Active Comparator: BabyGentleStick™ OFF
Active Comparator intervention to be compared to the Experimental Treatment.
|
Device: BabyGentleStick™ OFF |
- Absence of Adverse Events [ Time Frame: 24 hours after the intervention is received for each subject ]Subjects will receive a follow-up phone call 24 hours post-intervention to monitor adverse events.
- Reduced Pain Response [ Time Frame: Up to 8 weeks ]Relative pain scale from 1 to 10
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 29 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy adult volunteers 18-29 years of age.
- Fluent in written and spoken English
- Sex: male or female
Exclusion Criteria:
- Pregnant women
- Cognitive impairment
- Prisoner
- Individuals with known hematologic conditions or bleeding disorders
- Individuals with immune disorders where a finger lance puts them at risk for infection.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02947646
| United States, Pennsylvania | |
| Penn State Milton S. Hershey Medical Center | |
| Hershey, Pennsylvania, United States, 17033 | |
| Principal Investigator: | Ryan Clement, Ph.D. | Actuated Medical, Inc. | |
| Principal Investigator: | Kim K Doheny, Ph.D. | The Pennsylvania State University College of Medicine |
| Responsible Party: | Actuated Medical, Inc. |
| ClinicalTrials.gov Identifier: | NCT02947646 |
| Other Study ID Numbers: |
STUDY00004892 R41HD088139 ( U.S. NIH Grant/Contract ) |
| First Posted: | October 28, 2016 Key Record Dates |
| Last Update Posted: | January 24, 2018 |
| Last Verified: | January 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |

